{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:50:28Z","timestamp":1787061028056,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003761","name":"Universitair Medisch Centrum Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008955","name":"Wilhelmina Kinderziekenhuis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016032","name":"Nederlandse Cystic Fibrosis Stichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["TKI-LSH-DT2019-NCFS"],"award-info":[{"award-number":["TKI-LSH-DT2019-NCFS"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.eclinm.2023.102116","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T19:10:45Z","timestamp":1690485045000},"page":"102116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-2831","authenticated-orcid":false,"given":"Danya","family":"Muilwijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa J.","family":"van Paridon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris C.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Faber-Bisschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenique D.","family":"Zomer-van Ommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry G.M.","family":"Heijerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis K.","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2023.102116_bib1","series-title":"Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products","year":"2006"},{"key":"10.1016\/j.eclinm.2023.102116_bib2","series-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims","year":"2009"},{"key":"10.1016\/j.eclinm.2023.102116_bib3","doi-asserted-by":"crossref","first-page":"f167","DOI":"10.1136\/bmj.f167","article-title":"Patient reported outcome measures could help transform healthcare","volume":"346","author":"Black","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2023.102116_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2023.102116_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols","volume":"319","author":"Calvert","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2023.102116_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045105","article-title":"SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials","volume":"11","author":"Calvert","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2023.102116_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/17407745221077691","article-title":"The PROTEUS-Trials Consortium: optimizing the use of patient-reported outcomes in clinical trials","volume":"19","author":"Snyder","year":"2022","journal-title":"Clin Trials"},{"key":"10.1016\/j.eclinm.2023.102116_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/hex.13254","article-title":"Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues","volume":"24","author":"Churruca","year":"2021","journal-title":"Health Expect"},{"key":"10.1016\/j.eclinm.2023.102116_bib9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0895-4356(03)00132-X","article-title":"Responsiveness of goal attainment scaling in a randomized controlled trial of comprehensive geriatric assessment","volume":"56","author":"Rockwood","year":"2003","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2023.102116_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1469-8749.2007.00550.x","article-title":"Goal attainment scaling in paediatric rehabilitation: a critical review of the literature","volume":"49","author":"Steenbeek","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.eclinm.2023.102116_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0269215508101742","article-title":"Goal attainment scaling (GAS) in rehabilitation: a practical guide","volume":"23","author":"Turner-Stokes","year":"2009","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.eclinm.2023.102116_bib12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s10803-012-1446-7","article-title":"Goal attainment scaling as an outcome measure in randomized controlled trials of psychosocial interventions in autism","volume":"42","author":"Ruble","year":"2012","journal-title":"J\u00a0Autism Dev Disord"},{"key":"10.1016\/j.eclinm.2023.102116_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/0269215513490178","article-title":"The use of patient-specific measurement instruments in the process of goal-setting: a systematic review of available instruments and their feasibility","volume":"27","author":"Stevens","year":"2013","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.eclinm.2023.102116_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12874-019-0866-x","article-title":"Goal attainment scaling as an outcome measure in rare disease trials: a conceptual proposal for validation","volume":"19","author":"Gaasterland","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eclinm.2023.102116_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.eclinm.2023.102116_bib16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102116_bib17","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with Cystic Fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2023.102116_bib18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eclinm.2023.102116_bib19","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of the Cystic Fibrosis questionnaire in the United States","volume":"128","author":"Quittner","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.eclinm.2023.102116_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11136-018-2076-0","article-title":"Assessing test\u2013retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula","volume":"28","author":"Qin","year":"2019","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eclinm.2023.102116_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033867","article-title":"A\u00a0systematic review of patient-reported outcome measures (PROMs) in Cystic Fibrosis","volume":"10","author":"Ratnayake","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2023.102116_bib22","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.jcf.2021.02.009","article-title":"\u201cIl faut continuer \u00e0 poser des questions\u201d patient reported outcome measures in Cystic Fibrosis: an anthropological perspective","volume":"20","author":"Coucke","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.eclinm.2023.102116_bib23","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the cystic fibrosis questionnaire-revised respiratory symptom scale in two populations of patients with Cystic Fibrosis and chronic pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.eclinm.2023.102116_bib24","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with Cystic Fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102116_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor\u2013Ivacaftor in patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102116_bib26","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor\u2013Ivacaftor in patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2023.102116_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2022.08.018","article-title":"Non-respiratory health-related quality of life in people with Cystic Fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Fajac","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.eclinm.2023.102116_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1513\/AnnalsATS.201408-393OC","article-title":"A\u00a0systematic review of factors associated with health-related quality of life in adolescents and adults with Cystic Fibrosis","volume":"12","author":"Habib","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.eclinm.2023.102116_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4187\/respcare.06356","article-title":"Health-related quality of life in adolescents and adults with Cystic Fibrosis: physical and mental health predictors","volume":"64","author":"Cronly","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.eclinm.2023.102116_bib30","doi-asserted-by":"crossref","DOI":"10.2196\/15588","article-title":"Benefits and disadvantages of electronic patient-reported outcome measures: systematic review","volume":"3","author":"Meirte","year":"2020","journal-title":"JMIR Perioper Med"},{"key":"10.1016\/j.eclinm.2023.102116_bib31","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: defining what really matters to patients","volume":"312","author":"McGlothlin","year":"2014","journal-title":"JAMA"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537023002936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:23:47Z","timestamp":1762899827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537023002936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":31,"alternative-id":["S2589537023002936"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102116","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2023.102116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102116"}}